Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Mar;84(6):791–795. doi: 10.1054/bjoc.2000.1619

HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients

X Hu 1, T Pang 1, Z Guo 1, N Mazurenko 2, F Kisseljov 2, J Pontén 1, M Nistér 1
PMCID: PMC2363815  PMID: 11259093

Abstract

HPV16 is frequently seen in invasive cervical cancer (ICC) and cervical intraepithelial neoplasia (CIN). Its E6 gene has frequent sequence variations. Although some E6 variants have been reported to have different biochemical or biological properties, they do not show geographical identity. Moreover, the definition of ‘variant’ has been a source of confusion because it has been based on all departures from the ‘prototype’ once isolated randomly from an ICC case. We amplified the HPV16 E6 gene by PCR from fresh-frozen tissue of 104 cases of ICC and CIN from Russian patients and sequenced it in positive cases. We found that 32 of 55 (58.2%) ICC cases and 18 of 49 (36.7%) CIN cases were HPV 16-positive and we could identify 3 groups of E6 variants: group A was characterized by G at nt 350 where group B had T, and group M was a heterogeneous mixture of unique E6 variants; no significant difference existed in the distribution of the different groups between ICC and CIN; the clinically malignant (as defined by FIGO stage) order between the groups was M > A > B in ICC; in the cases with a single HPV16 E6 sequence, coexisting ICC, CIN and normal epithelium in the same patient shared the E6 variant; and 4 cases of ICC had double/multiple E6 variants. The results did not show any importance of E6 variants for ICC progression in Russian women. The results also indicated that the original HPV16 variant persisted during ICC progression, and that at a low frequency, double infections and/or mutation of variants might occur. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: HPV, sequence variation, cervical cancer, cancer in situ

Full Text

The Full Text of this article is available as a PDF (60.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bontkes H. J., van Duin M., de Gruijl T. D., Duggan-Keen M. F., Walboomers J. M., Stukart M. J., Verheijen R. H., Helmerhorst T. J., Meijer C. J., Scheper R. J. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer. 1998 Oct 5;78(2):166–171. doi: 10.1002/(sici)1097-0215(19981005)78:2<166::aid-ijc8>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  2. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Schiffman M. H., Moreno V., Kurman R., Shah K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995 Jun 7;87(11):796–802. doi: 10.1093/jnci/87.11.796. [DOI] [PubMed] [Google Scholar]
  3. Dyson N., Howley P. M., Münger K., Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989 Feb 17;243(4893):934–937. doi: 10.1126/science.2537532. [DOI] [PubMed] [Google Scholar]
  4. Ellis J. R., Keating P. J., Baird J., Hounsell E. F., Renouf D. V., Rowe M., Hopkins D., Duggan-Keen M. F., Bartholomew J. S., Young L. S. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med. 1995 May;1(5):464–470. doi: 10.1038/nm0595-464. [DOI] [PubMed] [Google Scholar]
  5. Eluf-Neto J., Booth M., Muñoz N., Bosch F. X., Meijer C. J., Walboomers J. M. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer. 1994 Jan;69(1):114–119. doi: 10.1038/bjc.1994.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hedrum A., Pontén F., Ren Z., Lundeberg J., Pontén J., Uhlén M. Sequence-based analysis of the human p53 gene based on microdissection of tumor biopsy samples. Biotechniques. 1994 Jul;17(1):118-9, 122-4, 126-9. [PubMed] [Google Scholar]
  7. Hu X., Guo Z., Tianyun P., Pontén F., Wilander E., Andersson S., Pontén J. HPV typing and HPV16 E6-sequence variations in synchronous lesions of cervical squamous-cell carcinoma from Swedish patients. Int J Cancer. 1999 Sep 24;83(1):34–37. doi: 10.1002/(sici)1097-0215(19990924)83:1<34::aid-ijc7>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  8. Londesborough P., Ho L., Terry G., Cuzick J., Wheeler C., Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer. 1996 Oct 21;69(5):364–368. doi: 10.1002/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  9. Luxton J., Mant C., Greenwood B., Derias N., Nath R., Shepherd P., Cason J. HPV16 E6 oncogene variants in women with cervical intraepithelial neoplasia. J Med Virol. 2000 Mar;60(3):337–341. [PubMed] [Google Scholar]
  10. Matsukura T., Sugase M. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer. 1995 Mar 29;61(1):13–22. doi: 10.1002/ijc.2910610104. [DOI] [PubMed] [Google Scholar]
  11. Mazurenko N., Attaleb M., Gritsko T., Semjonova L., Pavlova L., Sakharova O., Kisseljov F. High resolution mapping of chromosome 6 deletions in cervical cancer. Oncol Rep. 1999 Jul-Aug;6(4):859–863. doi: 10.3892/or.6.4.859. [DOI] [PubMed] [Google Scholar]
  12. Muñoz N., Bosch F. X., de Sanjosé S., Tafur L., Izarzugaza I., Gili M., Viladiu P., Navarro C., Martos C., Ascunce N. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992 Nov 11;52(5):743–749. doi: 10.1002/ijc.2910520513. [DOI] [PubMed] [Google Scholar]
  13. Phelps W. C., Münger K., Yee C. L., Barnes J. A., Howley P. M. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol. 1992 Apr;66(4):2418–2427. doi: 10.1128/jvi.66.4.2418-2427.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Samoylova E. V., Shaikhaiev G. O., Petrov S. V., Kisseljova N. P., Kisseljov F. L. HPV infection in cervical-cancer cases in Russia. Int J Cancer. 1995 May 4;61(3):337–341. doi: 10.1002/ijc.2910610311. [DOI] [PubMed] [Google Scholar]
  15. Sparén P., Gustafsson L., Friberg L. G., Pontén J., Bergström R., Adami H. O. Improved control of invasive cervical cancer in Sweden over six decades by earlier clinical detection and better treatment. J Clin Oncol. 1995 Mar;13(3):715–725. doi: 10.1200/JCO.1995.13.3.715. [DOI] [PubMed] [Google Scholar]
  16. Stöppler M. C., Ching K., Stöppler H., Clancy K., Schlegel R., Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol. 1996 Oct;70(10):6987–6993. doi: 10.1128/jvi.70.10.6987-6993.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990 Apr 6;248(4951):76–79. doi: 10.1126/science.2157286. [DOI] [PubMed] [Google Scholar]
  18. Wheeler C. M., Yamada T., Hildesheim A., Jenison S. A. Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol. 1997 Jan;35(1):11–19. doi: 10.1128/jcm.35.1.11-19.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Williams C., Pontén F., Moberg C., Söderkvist P., Uhlén M., Pontén J., Sitbon G., Lundeberg J. A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol. 1999 Nov;155(5):1467–1471. doi: 10.1016/S0002-9440(10)65461-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Xi L. F., Demers G. W., Koutsky L. A., Kiviat N. B., Kuypers J., Watts D. H., Holmes K. K., Galloway D. A. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis. 1995 Sep;172(3):747–755. doi: 10.1093/infdis/172.3.747. [DOI] [PubMed] [Google Scholar]
  21. Xi L. F., Koutsky L. A., Galloway D. A., Kuypers J., Hughes J. P., Wheeler C. M., Holmes K. K., Kiviat N. B. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst. 1997 Jun 4;89(11):796–802. doi: 10.1093/jnci/89.11.796. [DOI] [PubMed] [Google Scholar]
  22. Yamada T., Manos M. M., Peto J., Greer C. E., Munoz N., Bosch F. X., Wheeler C. M. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997 Mar;71(3):2463–2472. doi: 10.1128/jvi.71.3.2463-2472.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Yamada T., Wheeler C. M., Halpern A. L., Stewart A. C., Hildesheim A., Jenison S. A. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 1995 Dec;69(12):7743–7753. doi: 10.1128/jvi.69.12.7743-7753.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zehbe I., Wilander E., Delius H., Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998 Feb 15;58(4):829–833. [PubMed] [Google Scholar]
  25. van Muyden R. C., ter Harmsel B. W., Smedts F. M., Hermans J., Kuijpers J. C., Raikhlin N. T., Petrov S., Lebedev A., Ramaekers F. C., Trimbos J. B. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study. Cancer. 1999 May 1;85(9):2011–2016. [PubMed] [Google Scholar]
  26. von Knebel Doeberitz M., Rittmüller C., Aengeneyndt F., Jansen-Dürr P., Spitkovsky D. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J Virol. 1994 May;68(5):2811–2821. doi: 10.1128/jvi.68.5.2811-2821.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES